New York Life Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

New York Life Investment Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,930	Closed	-$347K	–	965
2024 Q1	$347K	Sell	8,930 -5,465	-38%	-$191K	﹤0.01%	1291
2023 Q4	$443K	Sell	14,395 -446	-3%	-$11.2K	﹤0.01%	920
2023 Q3	$332K	Sell	14,841 -2,338	-14%	-$53.3K	﹤0.01%	1057
2023 Q2	$369K	Sell	17,179 -2,505	-13%	-$56.9K	﹤0.01%	1111
2023 Q1	$472K	Sell	19,684 -8,179	-29%	-$217K	0.01%	1051
2022 Q4	$646K	Buy	27,863 +3,144	+13%	+$63.4K	0.01%	722
2022 Q3	$396K	Buy	24,719 +1,814	+8%	+$32K	﹤0.01%	953
2022 Q2	$406K	Buy	+22,905	New	+$385K	﹤0.01%	943

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

New York Life Investment Management's COLL Position: Q2 2024 in Review

New York Life Investment Management sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 8,930 shares — an estimated $347K sold.

New York Life Investment Management first reported a position in COLL in Q2 2022 and held it in 8 quarters. The position peaked at $646K in Q4 2022. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

New York Life Investment Management reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
New York Life Investment Management sold 8,930 Collegium Pharmaceutical shares in Q2 2024, an estimated $347K.
New York Life Investment Management first reported a position in Collegium Pharmaceutical in Q2 2022 and held it in 8 quarters.
New York Life Investment Management's Collegium Pharmaceutical position peaked at $646K in Q4 2022.
229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.